News

Encouragement to pharmaceutical companies to register medicines commonly used in Named Patient Programmes - 15.5.2020

The Icelandic Medicines Agency hereby publishes a list of the most commonly prescribed medicinal products in Named Patient Programmes in April 2020. The purpose of publishing this information is to encourage pharmaceutical companies to apply for marketing authorisations and market the products listed, or comparable medicines.

IMA services during the COVID-19 outbreak - 26.3.2020

Issues related to COVID-19 are considered highest priority within the IMA during these difficult times.

See all